thrombolytic


Also found in: Dictionary, Thesaurus, Wikipedia.

thrombolytic

 [throm″bo-lit´ik]
1. dissolving or splitting up a thrombus.
2. an agent such as streptokinase or urokinase that dissolves or splits up a thrombus. See also anticoagulant and antithrombotic.

throm·bo·lyt·ic

(throm'bō-lit'ik),
Breaking up or dissolving a thrombus.
Synonym(s): thromboclastic

thrombolytic

/throm·bo·lyt·ic/ (throm″bo-lit´ik) dissolving or splitting up a thrombus, or an agent that so acts.

thrombolytic

[-lit′ik]
Etymology: Gk, thrombos + lysis, a loosening
pertaining to a drug or another agent that dissolves a thrombus.

throm·bo·lyt·ic

(throm'bō-lit'ik)
Breaking up or dissolving a thrombus.
Synonym(s): thromboclastic.

thrombolytic

1. dissolving or splitting up a thrombus.
2. an agent that dissolves or splits up a thrombus.
References in periodicals archive ?
We believe the routine use of a thrombolytic agent on clotted blood and bone marrow specimens should become standard for all cytogenetics laboratories.
Thrombolytic therapy also increased the risk of in-hospital death by 75% in treated patients, compared with the risk in DVT patients who did not undergo thrombolysis.
The company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke.
Among the patients who stayed put and got thrombolytic drugs, 1 in 7--nearly twice the proportion--met such a fate within the month.
The mismatch is a marker for patients with a significant penumbra region in their brain, tissue that might be salvageable by thrombolytic therapy because it is still viable despite being hypoperfused.
Additional laboratory evaluation revealed peripheral eosinophilia, which was evident the day after thrombolytic agents were given and persisted until initiation of hemodialysis.
Each North-East Ambulance Service paramedic has a check list which they must follow before administering a thrombolytic drug.
There appear to be two mechanisms of benefit for thrombolytic therapy and heparin during CPR.
The present Competitive Intelligence report provides a completely updated competitor evaluation in the field of thrombolytic products and R&D projects as of April 2007.
The treatment is designed to combine greater thrombolytic efficacy with improved safety and we are eager to test it in the clinic together with the NINDS team.